Lilly Oncology President Anne White On Loxo Success, What’s To Come

New Approval And Novel BTK Drug Emerge After Cancer R&D Reconfiguration

 
• By Mandy Jackson

White said the late 2019 creation of Loxo Oncology at Lilly to spearhead cancer R&D has exceeded her expectations. The executive also discussed COVID-19’s impact on drug sales and cancer screening. 

Eli Lilly logo sign - San Diego, California, USA - 2020
Lilly Oncology's partnership with the Loxo research group has been productive • Source: Shutterstock

More from Anticancer

More from Therapy Areas